Yale’s Craig Crews leveraged basic science research that formed the basis of a cancer drug eventually valued at nearly $10 billion.Now Crews, the Lewis B. Cullman Professor of Molecular, Cellular and Developmental Biology and professor of chemistry and...
The Yale Center for Biomedical and Interventional Technology (CBIT) will lead a new $1 million seed grant program over two years from the Connecticut BioScience Innovation Fund to support commercialization of new biomedical ideas from Connecticut...
A nanoparticle-based sunscreen and new method to detect bloodstream infections are just two projects inspired by Yale faculty that will receive support from a $1 million Connect Innovations program designed to spur creation of new biomedical device...